ACET Q4 2019 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+100.5% YoY

Gross Profit

-$222M-11266.8% margin

Operating Income

-$7M-364.5% margin

Net Income

-$7M-334.1% margin

EPS (Diluted)

$-5.60

QoQ Revenue Growth

+127.9%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$310,000

Balance Sheet

Total Assets

$82M

Total Liabilities

$142M

Stockholders' Equity

-$60M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	-$431M	+100.5%
Gross Profit	-$222M	-$749M	+70.4%
Operating Income	-$7M	-$89M	+91.9%
Net Income	-$7M	-$68M	+90.3%